| Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain. | |
| | |
MedLine Citation:
|
PMID: 19715885 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Toxic cardiomyopathies are rare and the most frequent cause are anthracycline compounds. Early acute toxicity can be reversible, but at present the only effective therapy for late end-stage anthracycline cardiomyopathy seems to be a heart transplantation. Currently, this transplantation is contraindicated in cases of cancer, at least during the first 4 or 5 years. Recently, implantable axial pumps have shown good results and are used with increasing frequency as destination therapy. METHODS: We present a case of end-stage heart failure due to a toxic cardiomyopathy after a bilateral breast cancer treated with resection and chemotherapy (doxorubicin and trastuzumab). Ejection fraction was 23% with dobutamine. A left ventricular axial pump (Incor) was implanted. RESULTS: The immediate postoperative course was uneventful. The left ventricular function improved and on the fourth month the ejection fraction was 55%. On postoperative day 135, the pump was explanted. After 1.5 years, the patient is doing well, with an ejection fraction of 57%. CONCLUSION: This is the first application of an implantable axial pump in Spain. Although toxic cardiomyopathies are rare, in cases of late end-stage left ventricular failure and when the heart transplantation is contraindicated, the implantation of an axial pump can be the solution. The results in previous cases are unknown, although it is possible, as in our case. |
| | |
Authors:
|
E Castells; J Roca; A Miralles; N Manito; D Ortiz; J Gonzalez; J Granados; M Benito; M Rabasa; F S'braga; J Toscano; D Toral; A L??pez; C Fontanillas |
Related Documents
:
|
16269455 - Oleylethanolamide activates ras-erk pathway and improves myocardial function in doxorub... 7567755 - Angiography and the aetiology of heart failure. 7618765 - Ischemic cardiomyopathy without significant coronary stenosis. a case report. 8427135 - The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates an... 7245495 - Mechanical circulatory assistance for postoperative cardiogenic shock: a three year exp... 6411445 - Tocainide. a review of its pharmacological properties and therapeutic efficacy. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Transplantation proceedings Volume: 41 ISSN: 1873-2623 ISO Abbreviation: Transplant. Proc. Publication Date: 2009 Jul-Aug |
Date Detail:
|
Created Date: 2009-08-31 Completed Date: 2010-01-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0243532 Medline TA: Transplant Proc Country: United States |
Other Details:
|
Languages: eng Pagination: 2237-9 Citation Subset: IM |
Affiliation:
|
Department of Cardiac Surgery, Bellvitge University Hospital IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. castellscuch@bellvitgehospital.cat |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anthracyclines / toxicity Breast Neoplasms / complications Cardiomyopathies / chemically induced, complications*, pathology, surgery Disease Progression Female Heart Transplantation / statistics & numerical data* Heart-Assist Devices* Humans Patient Selection Prostheses and Implants Spain Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anthracyclines |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant my...
Next Document: Gene expression profiling for monitoring graft rejection in heart transplant recipients.